I think it'll take some pretty spectacular news to
Post# of 15624
(Total Views: 510)
Posted On: 03/10/2018 5:28:50 PM
I think it'll take some pretty spectacular news to get to $3 or $4, but yes, I will agree it's POSSIBLE at some point in 2018. Again, only with some kind of big news.
I highly recommend people don't start buying shares at $2.00 if it does start to run because "people said it would go to $4!"
I like to think realistic, despite the fact that OTC is full of unrealistic. Market Cap.
$3.00 per share is an estimated $443 million. But, we can look at companies like CNBX and AXIM to see it's possible for OWC to rise to that level. Though, unless the news is substantial and represents something true vs. pure hype and hope... It'll come back down again, IMO.
If a big JV is announced with a Big Pharma type name and the Cream is said to be available for sale in Europe, Germany, Canada, or even California by, say, Summer or Fall. Yes. That can help sustain $443M (or more).
I remind you all once again that AstraZeneca auctioned off it's "troubled" Psoriasis drug that was linked to suicide for $445M. (Source: https://www.fiercebiotech.com/partnering/astr...445m-deal)
So, if the studies continue to prove this topical cream will be a success... That market cap can legitimately rise. Even $1B+ becomes a realistic scenario.
(Note: GWPH has a market cap near $3B without a product on the market)
I highly recommend people don't start buying shares at $2.00 if it does start to run because "people said it would go to $4!"
I like to think realistic, despite the fact that OTC is full of unrealistic. Market Cap.
$3.00 per share is an estimated $443 million. But, we can look at companies like CNBX and AXIM to see it's possible for OWC to rise to that level. Though, unless the news is substantial and represents something true vs. pure hype and hope... It'll come back down again, IMO.
If a big JV is announced with a Big Pharma type name and the Cream is said to be available for sale in Europe, Germany, Canada, or even California by, say, Summer or Fall. Yes. That can help sustain $443M (or more).
I remind you all once again that AstraZeneca auctioned off it's "troubled" Psoriasis drug that was linked to suicide for $445M. (Source: https://www.fiercebiotech.com/partnering/astr...445m-deal)
So, if the studies continue to prove this topical cream will be a success... That market cap can legitimately rise. Even $1B+ becomes a realistic scenario.
(Note: GWPH has a market cap near $3B without a product on the market)
(1)
(0)